Clinical Trial Update: A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sintilimab in combination with concurrent chemoradiation therapy for locally advanced cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Cervical Neoplasms

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: The Affiliated Hospital of Xuzhou Medical University | Conditions: Uterine Cervical Neoplasms, Sintilimab | Phase 2 | Status: UNKNOWN